Immunecheckpoint inhibition for metastatic triplenegative breast cancer safety first

Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?

07:48 EDT 4 May 2019 | Nature Publishing

More From BioPortfolio on "Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?"